Paul A Laviolette insider trades
Open-market stock purchases and sales by Paul A Laviolette, Chief Executive Officer at Pulse Biosciences, Inc, from SEC Form 4 filings since May 19, 2010.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +26%.
Companies traded
- PLSE Pulse Biosciences, Inc: 2 buys, last May 11, 2026
- EW Edwards Lifesciences Corp: other filings, last May 8, 2026
- MSON Misonix Inc: other filings, last Oct 29, 2021
- ASXC Asensus Surgical, Inc: other filings, last Jul 1, 2021
- TRXC Transenterix, Inc: other filings, last Dec 31, 2020
- THOR Thoratec Corp: 3 sales, last Oct 8, 2015
- BAXS Baxano Surgical, Inc: other filings, last Apr 17, 2014
- CPTS Conceptus Inc: other filings, last Jun 5, 2013
- TSON Trans1 Inc: other filings, last Jun 5, 2012